← FDA DRUG APPROVALS

FDA NDA · NDA202049

BRONCHITOL

Sponsor: PHARMAXIS EUROPE

APPLICATION
NDA202049
TYPE
NDA
ORIGINAL APPROVAL
2020-10-30
LATEST ACTION
2020-10-30
ROUTE
INHALATION
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription

Products

BRONCHITOL · ReferencePrescription
MANNITOL 40MG · POWDER · INHALATION

Approval history

2020-10-30Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated · Original · standardLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →